Physician profile
David A Blanco
NPI 1619198769
$1,175.80
in general payments reported to CMS, 2019-2025
11 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2021: $227 · 2022: $345 · 2023: $227 · 2024: $131 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $309.28 | 2021-2023 | Kristalose |
| Genzyme Corporation | $292.77 | 2022-2025 | |
| Abbvie INC. | $149.99 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $142.86 | 2021-2024 | Gattex, Eohilia |
| Nestle Healthcare Nutrition INC. | $124.74 | 2023 | |
| Pfizer INC. | $43.87 | 2024 | |
| Travere Therapeutics, INC. | $30.13 | 2021 | |
| Celltrion USA INC. | $30.08 | 2025 | Vegzelma |
| Regeneron Healthcare Solutions, INC. | $19.31 | 2022 | |
| Qol Medical, LLC | $17.84 | 2022 | |
| Mirum Pharmaceuticals, INC. | $14.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.